Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Artivion, Inc.

Market Cap 102.86Cr 90Cr 83Cr 78Cr 145.83Cr 9.71TCr 146.71Cr 985.41Cr 381.9Cr 4.78TCr 386.12Cr 377.84Cr 17TCr P/E 2026 *
171x
P/E 2027 * 49.6x
Enterprise Value 102.86Cr 90Cr 83Cr 78Cr 145.83Cr 9.71TCr 146.71Cr 985.41Cr 381.9Cr 4.78TCr 386.12Cr 377.84Cr 17TCr EV / Sales 2026 *
2.11x
EV / Sales 2027 * 1.9x
Free-Float
89.39%
Yield 2026 *
-
Yield 2027 * -
1 day-1.08%
1 week+3.39%
Current month-5.18%
1 month-11.17%
3 months-42.36%
6 months-54.19%
Current year-53.14%
1 week 17.6
Extreme 17.6
18.5
1 month 17.4
Extreme 17.4
19.9
Current year 17.4
Extreme 17.4
38.9
1 year 17.4
Extreme 17.4
41.1
3 years 11.7
Extreme 11.7
41.1
5 years 10.1
Extreme 10.1
41.1
10 years 10.1
Extreme 10.1
41.1
Manager TitleAgeSince
Chief Executive Officer 59 02/09/2014
Director of Finance/CFO 53 04/12/2023
Chief Tech/Sci/R&D Officer 69 01/03/2021
Director TitleAgeSince
Director/Board Member 61 01/05/2012
Director/Board Member 71 01/12/2003
Director/Board Member 66 01/12/2003
Change 5-day change 1-year change 3-year change Capi.($)
-1.08%+3.39% - - 102.86Cr
-0.10%+0.26%-33.23%-16.75% 15TCr
+1.54%-1.07%-7.45%-11.00% 10TCr
-4.45%+3.12%+59.84%+56.09% 5.65TCr
-1.90%-3.49%-8.40%+48.53% 5.29TCr
+1.67%-1.55%-14.60%-44.33% 3.97TCr
-1.32%-1.83% - - 3.04TCr
+1.74%-3.85%-10.54%-44.30% 2.8TCr
+1.35%-0.26%+50.47%-9.42% 2.32TCr
-1.53%+1.14%-15.03%-5.42% 2.03TCr
Average -0.41%-1.30%+2.63%-3.32% 5.63TCr
Weighted average by Cap. -0.27%-1.24%-6.19%-2.71%

Financials

2026 *2027 *
Net sales 49Cr 42Cr 39Cr 37Cr 69Cr 4.59TCr 69Cr 465.97Cr 180.59Cr 2.26TCr 182.58Cr 178.67Cr 7.84TCr 54Cr 47Cr 44Cr 41Cr 77Cr 5.1TCr 77Cr 517.29Cr 200.48Cr 2.51TCr 202.69Cr 198.35Cr 8.71TCr
Net income 51.06L 44.52L 41.23L 38.6L 72.38L 48Cr 72.82L 4.89Cr 1.9Cr 24Cr 1.92Cr 1.88Cr 82Cr 2.26Cr 1.97Cr 1.83Cr 1.71Cr 3.21Cr 213.36Cr 3.23Cr 22Cr 8.4Cr 105.02Cr 8.49Cr 8.31Cr 364.65Cr
Net Debt - -
Logo Artivion, Inc.
Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons in treating patients with aortic diseases. The Company operates through two segments, which include Medical Devices and Preservation Services. The Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other products. The Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. It has four product families: aortic stent grafts, On-X mechanical heart valves and related surgical products, surgical sealants, and implantable cardiac and vascular human tissues. Its aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Its surgical sealants include BioGlue Surgical Adhesive products. It is engaged in the endovascular repair of aortic arch disease and the developer of the NEXUS Aortic Arch System.
Employees
1,800
Date Price Change
19/26/19 18.30 -1.08%
18/26/18 18.50 +0.54%
17/26/17 18.40 +1.66%
16/26/16 18.10 +2.84%
15/26/15 17.60 -0.56%
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
21.19USD
Average target price
42.00USD
Spread / Average Target
+98.21%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!